Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 6/20 | 0.54 |
| ▸ | ACHE | P22303 | 2/20 | 0.47 |
| ▸ | BCHE | P06276 | 1/20 | 0.47 |
| ▸ | GPR3 | P46089 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | HRH1 | P35367 | 4/20 | 0.40 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.40 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.40 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.40 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.40 |
| ▸ | DRD3 | P35462 | 2/20 | 0.40 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | DRD2 | P14416 | 1/20 | 0.40 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL313685 | 0.88 | ACHE (0.55) | HTR2AACHEBCHEGPR3CA1 | |
| SCHEMBL877438 | 0.86 | HTR2A (0.56) | HTR2AACHEBCHE | |
| SCHEMBL5353138 | 0.85 | HTR2A (0.64) | HTR2AACHEBCHEGPR3CA1 | |
| SCHEMBL1449246 | 0.85 | HTR2A (0.54) | HTR2AACHEBCHE | |
| SCHEMBL407781 | 0.85 | HTR2A (0.54) | HTR2AACHEBCHE | |
| SCHEMBL6061696 | 0.85 | HTR2A (0.54) | HTR2AACHEBCHE | |
| SCHEMBL6060761 | 0.85 | HTR2A (0.54) | HTR2AACHEBCHE | |
| SCHEMBL6060915 | 0.85 | HTR2A (0.54) | HTR2AACHEBCHE | |
| SCHEMBL6060938 | 0.85 | HTR2A (0.54) | HTR2AACHEBCHE | |
| SCHEMBL6060774 | 0.85 | HTR2A (0.54) | HTR2AACHEBCHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111269401-B | Polymer containing piperidine tertiary amine group, anion exchange polymer, and preparation method and application thereof | 惠州市亿纬新能源研究院 | 2023-12-05 | — | — | CN | claimed |
| CN-111269401-A | Polymer containing piperidine tertiary amine group, anion exchange polymer, and preparation methods and applications thereof | 惠州市亿纬新能源研究院 | 2020-06-12 | — | — | CN | claimed |
| CN-111269401-B | Polymer containing piperidine tertiary amine group, anion exchange polymer, and preparation method and application thereof | 惠州市亿纬新能源研究院 | 2023-12-05 | — | — | CN | disclosed |
| EP-4257196-A1 | DISCOVERY OF YEATS2 YEATS DOMAIN INHIBITORS AS NOVEL ANTI-CANCER AGENTS | The University of Hong Kong (HK) | 2023-10-11 | — | — | EP | disclosed |
| CN-111269401-A | Polymer containing piperidine tertiary amine group, anion exchange polymer, and preparation methods and applications thereof | 惠州市亿纬新能源研究院 | 2020-06-12 | — | — | CN | disclosed |
| US-8969624-B2 | Cyclopentadienyl, indenyl or fluorenyl substituted phosphine compounds and their use in catalytic reactions | EVONIK DEGUSSA GMBH (DE) | 2015-03-03 | — | — | US | disclosed |
| EP-2057174-B1 | NEW CYCLOPENTADIENYL, INDENYL OR FLUORENYL SUBSTITUTED PHOSPHINE COMPOUNDS AND THEIR USE IN CATALYTIC REACTIONS | EVONIK DEGUSSA GMBH (DE) | 2014-12-17 | — | — | EP | disclosed |
| US-20140058101-A1 | New Cyclopentadienyl, Indenyl or Fluorenyl Substituted Phosphine Compounds and Their Use in Catalytic Reactions | EVONIK DEGUSSA GMBH (DE) | 2014-02-27 | — | — | US | disclosed |
| US-8618328-B2 | Cyclopentadienyl, indenyl or fluorenyl substituted phosphine compounds and their use in catalytic reactions | EVONIK DEGUSSA GMBH (DE) | 2013-12-31 | — | — | US | disclosed |
| CN-101622264-B | Cyclopentadienyl, indenyl or fluorenyl substituted phosphine compounds and their use in catalytic reactions | EVONIK DEGUSSA GMBH | 2013-09-18 | — | — | CN | disclosed |
| US-8319213-B2 | Aryl-aryl dendrimers | ISIS INNOVATION LIMITED (GB) | 2012-11-27 | — | — | US | disclosed |
| US-20030027017-A1 | Light emitter for a display | HULL, UNIVERSITY OF (GB) | 2003-02-06 | — | — | US | disclosed |
| US-20030021913-A1 | Liquid crystal alignment layer | CENTRAL RESEARCH LABORATORIES LIMITED (GB) | 2003-01-30 | — | — | US | disclosed |
| US-20030018097-A1 | Light emitting polymer | HULL, UNIVERSITY OF (GB) | 2003-01-23 | — | — | US | disclosed |
| WO-2002067343-A1 | ARYL-ARYL DENDRIMERS | ISIS INNOVATION LIMITED (GB) | 2002-08-29 | — | — | WO | disclosed |
| EP-1180765-A1 | Optical recording medium and porphycene compound | Mitsui Chemicals, Inc. (JP) | 2002-02-20 | — | — | EP | disclosed |
| US-6197990-B1 | REACTING CYCLOPENTADIENE AND METAL HYDRIDE IN PRESENCE OF AMINE COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2001-03-06 | — | — | US | disclosed |
| US-6106999-A | SENSITIVITY TO GENERAL-PURPOSE VISIBLE LIGHT LASER, SO THAT HIGH-SPEED SCANNING EXPOSURE IS POSSIBLE BY LASER, AND EXTREMELY FINE HIGH RESOLUTION CAN BE OBTAINED; CAN BE USED FOR COATING OR PRINTING UNDER SAFELIGHT IRRADIATING CONDITIONS | MITSUI CHEMICALS (JP) | 2000-08-22 | — | — | US | disclosed |
| EP-0963990-A1 | PROCESS FOR PRODUCING CYCLOPENTADIENYL METAL SALTS AND PROCESS FOR PRODUCING CYCLOPENTADIENE DERIVATIVES BY UTILIZING THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1999-12-15 | — | — | EP | disclosed |
| CN-1147522-A | Bridged bis-fluorenyl metallocenes, process for preparation thereof and use thereof in catalysts for polymerization of olefins | MONTELL TECHNOLOGY COMPANY BV (NL) | 1997-04-16 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140058101-A1 | New Cyclopentadienyl, Indenyl or Fluorenyl Substituted Phosphine Compounds and Their Use in Catalytic Reactions | CPS1, CYCS, PFAS | HTR2A 3917/4885ACHE 2917/4885BCHE 1468/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.